Chloroquine: Autophagy inhibitor, antimalarial, bitter taste receptor agonist in fight against COVID-19, a reality check?

The recent SARS-CoV-2 pandemic poses one of the greatest challenges to modern medicine. Therefore, identification of new therapeutic strategies seems essential either based on novel vaccines or drugs or simply repurposing existing drugs. Notably, due to their known safety profile, repurposing of exi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Pawan, McAlinden, Kielan D., Ghavami, Saeid, Deshpande, Deepak A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857018/
https://www.ncbi.nlm.nih.gov/pubmed/33545161
http://dx.doi.org/10.1016/j.ejphar.2021.173928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857018/
https://www.ncbi.nlm.nih.gov/pubmed/33545161
http://dx.doi.org/10.1016/j.ejphar.2021.173928

Ejemplares similares